Aerpio Therapeutics' Reverse Merger Round

Aerpio Therapeutics raised a round of funding on March 16, 2017. Investors include Aerpio Pharmaceuticals.

Aerpio Therapeutics is a clinical‐stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases. Aerpio is a leader in the development of small molecule drugs based…

Articles about Aerpio Therapeutics' Reverse Merger Round: